
|Videos|May 26, 2022
Choosing a Combination Therapy for Renal Cell Carcinoma Before and After CLEAR Data
Author(s)Brian Shimkus, MD, Tom Powles, MBBS, MRCP, MD
Brian Shimkus, MD, discusses how he chose between RCC combination therapies before CLEAR trial data, and how the data influences his decisions now.
Advertisement
Episodes in this series

Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Relacorilant Combo in Platinum-Resistant Ovarian Cancers
2
FDA Clears Investigator-Initiated IND for SRN-101 in Recurrent High-Grade Glioma
3
The Evolution of Artificial Intelligence in Oncology: Impact on Trials, Workflows, and Outcomes
4
Navigating New Horizons in Neuroendocrine Prostate Cancer
5


































































